Shah Tahir, Isaac John, Adams David, Kelly Deirdre
University Hospital Birmingham and Birmingham Children's Hospital, Birmingham, UK.
Pediatr Transplant. 2005 Feb;9(1):127-31. doi: 10.1111/j.1399-3046.2004.00221.x.
Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPH) are pulmonary vascular disorders which occur in patients with severe liver disease and/or portal hypertension. Although these syndromes are frequently diagnosed in patients undergoing assessment for liver transplantation, they seldom occur in the same patient.
This report describes a female paediatric patient, born with extra-hepatic biliary atresia, who required liver transplantation, at the age of 15, for secondary biliary cirrhosis. She had severe HPS prior to her first liver transplant, which resolved rapidly following surgery, as well as indirect evidence for PPH. She required a second liver transplant 1 yr later for chronic rejection. Whilst evaluating the patient for a third liver transplant, 4 yr later, severe PPH was discovered. The patient died 3 months later from right heart failure.
HPS and PPH may coexist however they may show differing responses to liver transplantation with progression of PPH despite the resolution of HPS.
肝肺综合征(HPS)和门肺高压(PPH)是发生于严重肝病和/或门脉高压患者的肺血管疾病。尽管这些综合征常在接受肝移植评估的患者中被诊断出来,但它们很少发生在同一患者身上。
本报告描述了一名患有肝外胆道闭锁的女性儿科患者,她在15岁时因继发性胆汁性肝硬化需要进行肝移植。她在首次肝移植前患有严重的HPS,术后迅速缓解,同时有PPH的间接证据。1年后,她因慢性排斥反应需要进行第二次肝移植。4年后,在评估患者是否进行第三次肝移植时,发现了严重的PPH。患者3个月后死于右心衰竭。
HPS和PPH可能共存,然而它们对肝移植可能表现出不同的反应,尽管HPS得到缓解,但PPH仍会进展。